MiNK Therapeutics, Inc.
INKT
$14.72
-$0.44-2.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.23M | 4.58M | 6.33M | 9.31M | 5.82M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 236.20K | 246.60K | 235.80K | 98.80K | 59.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 108.70K | 164.20K | 11.20K | 61.10K | 122.50K |
| Total Current Assets | 3.58M | 4.99M | 6.58M | 9.47M | 6.00M |
|
|
|||||
| Total Current Assets | 3.58M | 4.99M | 6.58M | 9.47M | 6.00M |
| Net Property, Plant & Equipment | 687.50K | 732.90K | 799.50K | 850.00K | 895.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.27M | 5.72M | 7.37M | 10.32M | 6.89M |
|
|
|||||
| Total Accounts Payable | 2.66M | 2.73M | 2.36M | 3.20M | 3.49M |
| Total Accrued Expenses | 1.97M | 1.87M | 2.65M | 4.63M | 5.28M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.12M | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 2.37M | 2.36M | 2.39M | 2.32M | 2.34M |
| Total Other Current Liabilities | 2.37M | 2.36M | 2.39M | 2.32M | 2.34M |
| Total Current Liabilities | 12.12M | 6.96M | 7.40M | 10.15M | 11.11M |
|
|
|||||
| Total Current Liabilities | 12.12M | 6.96M | 7.40M | 10.15M | 11.11M |
| Long-Term Debt | -- | 4.92M | 4.61M | 4.41M | 4.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.94M | 13.42M | 12.92M | 12.35M | 11.87M |
| Total Liabilities | 26.06M | 25.31M | 24.93M | 26.90M | 27.19M |
|
|
|||||
| Common Stock & APIC | 125.82M | 125.23M | 124.84M | 123.95M | 117.30M |
| Retained Earnings | -146.95M | -144.18M | -141.72M | -139.91M | -137.21M |
| Treasury Stock & Other | -662.40K | -631.60K | -672.80K | -611.40K | -385.80K |
| Total Common Equity | -21.79M | -19.59M | -17.55M | -16.58M | -20.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.79M | -19.59M | -17.55M | -16.58M | -20.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.79M | -19.59M | -17.55M | -16.58M | -20.30M |
|
|
|||||